Mansfield ChadYour guide to events across Mansfield and Ashfield, 5th – 12th DecemberMansfield ChadReiki, reflexology, Body Talk, Indian head massage and healing. Wednesdays, 10.30am to 1pm. Donations, guidance, £5. MANSFIELD: Knit 'n' natter,…
Asheville area holiday eventsAsheville Citizen-Times“Holiday Pipes Plus” organ concert, 2 p.m. Dec. 8, Brevard-Davidson River Presbyterian Church, 249 E. Main St., Brevard. Free but donations are accepted for Sharing House. 884-2645. Celebration Si…
Swap hope for kidney patientsTimes of IndiaSwap transplant – a relatively new concept in India – is a viable solution for kidney failure patients who have a prospective donor, but with an unmatched blood group. Some doctors are now maintaining a databa…
Clinical Oncology NewsHematology & Stem Cell Transplantation ProgramClinical Oncology NewsThe majority of clinical responses with SAR3419 were seen in patients with follicular lymphoma, including those who were rituximab refractory. SAR3419 (huB4-D…
Astellas Announces Acceptance of US New Drug Application for Tacrolimus …International Business Times (press release)NORTHBROOK, Ill., Dec. 4, 2012 /PRNewswire/ — Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Aste…
B-cell alterations in ME/CFS 'may suggest subtle tendency to autoimmunity'ProHealthHowever, treatment with anti-B-cell therapy using Rituximab has recently shown benefit to CFS patients. We therefore postulated that patients with CFS had a subt…
Astellas Announces Acceptance of U.S. New Drug Application for Tacrolimus …PR Newswire (press release)NORTHBROOK, Ill., Dec. 4, 2012 /PRNewswire/ — Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc…
NORTHBROOK, Ill., Dec. 4, 2012 /PRNewswire/ — Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that the U.S. Food and …
New rheumatoid arthritis drug targets NIH-discovered proteinPharmaceutical ProcessingIn 1993, shortly after O'Shea and his team discovered the JAK3 protein and established its role in inflammation, O'Shea learned that scientists at Pfizer were …
New rheumatoid arthritis drug targets NIH-discovered proteinNational Institutes of Health (press release)In 1993, shortly after O'Shea and his team discovered the JAK3 protein and established its role in inflammation, O'Shea learned that scient…